| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |